Eisai
4523.T
#2122
Rank
NZ$12.81 B
Marketcap
$45.42
Share price
-2.42%
Change (1 day)
-35.46%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): NZ$0.72 Billion

According to Eisai's latest financial reports the company's current earnings are NZ$5.06 Billion. In 2023 the company made an earning of NZ$0.87 Billion, an increase over its 2022 earnings that were of -NZ$38.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.72 B-17.53%
2023 NZ$0.87 B-2392.87%
2022 -NZ$38.18 Million-103.6%
2021 NZ$1.06 B-39.52%
2020 NZ$1.75 B7.3%
2019 NZ$1.63 B17.23%
2018 NZ$1.39 B86.06%
2017 NZ$0.74 B-23.64%
2016 NZ$0.98 B27.28%
2015 NZ$0.77 B22.08%
2014 NZ$0.63 B-46.11%
2013 NZ$1.17 B-21.67%
2012 NZ$1.49 B-20.72%
2011 NZ$1.88 B-8.44%
2010 NZ$2.06 B18.85%
2009 NZ$1.73 B